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Modeling the growth dynamics of multiple
Escherichia coli strains in the pig intestine
following intramuscular ampicillin
treatment
Amais Ahmad1*† , Camilla Zachariasen2†, Lasse Engbo Christiansen3, Kaare Græsbøll3, Nils Toft4,
Louise Matthews5, Søren Saxmose Nielsen1 and John Elmerdahl Olsen2
Abstract
Background: This study evaluated how dosing regimen for intramuscularly-administered ampicillin, composition of
Escherichia coli strains with regard to ampicillin susceptibility, and excretion of bacteria from the intestine affected
the level of resistance among Escherichia coli strains in the intestine of nursery pigs. It also examined the dynamics
of the composition of bacterial strains during and after the treatment. The growth responses of strains to ampicillin
concentrations were determined using in vitro growth curves. Using these results as input data, growth predictions
were generated using a mathematical model to simulate the competitive growth of E. coli strains in a pig intestine
under specified plasma concentration profiles of ampicillin.
Results: In vitro growth results demonstrated that the resistant strains did not carry a fitness cost for their
resistance, and that the most susceptible strains were more affected by increasing concentrations of antibiotics that
the rest of the strains. The modeling revealed that short treatment duration resulted in lower levels of resistance
and that dosing frequency did not substantially influence the growth of resistant strains. Resistance levels were
found to be sensitive to the number of competing strains, and this effect was enhanced by longer duration of
treatment. High excretion of bacteria from the intestine favored resistant strains over sensitive strains, but at the
same time it resulted in a faster return to pre-treatment levels after the treatment ended. When the duration of
high excretion was set to be limited to the treatment time (i.e. the treatment was assumed to result in a cure of
diarrhea) resistant strains required longer time to reach the previous level.
Conclusion: No fitness cost was found to be associated with ampicillin resistance in E. coli. Besides dosing factors,
epidemiological factors (such as number of competing strains and bacterial excretion) influenced resistance
development and need to be considered further in relation to optimal treatment strategies. The modeling
approach used in the study is generic, and could be used for prediction of the effect of treatment with
other drugs and other administration routes for effect on resistance development in the intestine of pigs.
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Background
Antimicrobial resistance threatens the efficacy of avail-
able antibacterial drugs. High resistance levels are dir-
ectly linked with excessive and routine antimicrobial
use, and antimicrobial exposure in food production ani-
mals contributes significantly to increased antimicrobial
resistance [1]. Limiting the use of antimicrobials can re-
duce the prevalence of resistance. However, treatment of
production animals cannot be avoided for animal welfare
and economic purposes. It is therefore important to find
ways to reduce resistance, while maintaining the capacity
to treat diseased animals.
During treatment of infection, antimicrobial pressure
affects non-target commensal bacteria. This disturbance
may create large pools of resistant bacteria that could
lead to a general increase and spread of antimicrobial re-
sistance [2]. The major organ of concern is the intestine,
since it contains the highest number of bacteria at risk,
and confers a means of direct transfer of resistant bac-
teria via feces.
A possible way to reduce antimicrobial use is to treat
animals individually by injection treatment, rather than
using flock treatment, and this is commonly used for es-
pecially respiratory and systemic diseases in the pig in-
dustry. In doing so, the intestinal flora will be newer-
the-less be subjected to selection by the antibiotic, and it
is thus important to determine how best to reduce this
selection pressure. This study specifically examines how
individual treatment of pigs by injection with ampicillin
affects the levels of resistance in commensal Escherichia
coli in the intestines of pigs, using a modeling approach.
E. coli are commensal bacteria commonly used as indi-
cators of antimicrobial resistance in animals, humans and
food products [3–5]. They readily exchange antibiotic-
resistant genes, not only between strains of the species,
but also with other bacteria including those pathogenic to
humans [6], and their resistance levels in livestock herds
generally reflects the overall antimicrobial pressure in
these herds [7]. In Denmark, an average of 29 % of E. coli
isolates collected from healthy pigs and 33 % of pork iso-
lates from slaughterhouse samples were found to be resist-
ant to ampicillin in 2012 [8].
In simple terms, antimicrobial pressure favors a resist-
ant population because the susceptible population is
inhibited or killed by antimicrobial activity. However, the
relationship between antibiotic concentrations, the nat-
ural variation in sensitivity in the bacterial population,
and the outcome in terms of strain selection is very
complex, which makes it difficult to study this problem
using a traditional experimental approach.
Mathematical modeling techniques are frequently used
to investigate antibiotic resistance [9]. Such models are
based on in vitro and in vivo studies, and allow rapid
analysis of dosing strategies to help overcome the
problem of emergence of antimicrobial resistance [10].
Most modeling studies for optimizing treatment strat-
egies have been based on point estimates (e.g. minimum
inhibitory concentration (MIC), maximum drug concen-
tration (Cmax), and area under the concentration time
curve (AUC)) for a few strains of bacteria [11–13]. In
contrast, newer models include the full time-course of
pharmacokinetic (PK) and pharmacodynamic (PD) as-
pects, providing greater insight and a more accurate de-
scription of antimicrobial dosing strategies [14–19].
However, even these studies have been based on very
few (sometimes only one) clinical bacterial strains, pro-
viding a poor reflection of the within-host bacterial
dynamics. Pigs are co-colonized with a number of com-
mensal E. coli strains, both sensitive and resistant ones,
and there is a need to develop models that encompass
the growth response of a more realistic strain collection,
to obtain modeling results that better reflect real pig
production systems.
Mathematical models used so far have not accounted
for differences in the number of competing strains, or in
the composition of strains with different susceptibilities,
on the effect of a given treatment strategy [20–22]. In
contrast, in the present study, we have specifically mod-
eled the effect of strain composition and number on the
selection of resistant bacteria after ampicillin intramus-
cular (IM) treatment. Our primary objectives were to: 1)
characterize the growth response of 50 E. coli strains
when treated with ampicillin over a wide concentration
range based on a PD model; 2) predict the competitive
growth of randomly selected E. coli strains in a pig
under drug exposure based on in vivo PK data from
ampicillin IM treatment; 3) assess the optimum dose
level, dosing frequency and treatment duration to sup-
press or delay the growth of resistant strains; and 4)
analyze the importance of bacterial excretion (diarrhea),
and number of resistant bacteria prior to treatment, on
the buildup of resistance.
Results
The aim of this study was to determine how different
treatment strategies and characters of the intestinal flora
of pigs affected the growth of ampicillin-resistant and
sensitive strains following IM treatment with ampicillin.
To achieve this aim, the study comprised three steps: 1)
estimation of pharmacodynamic parameters of a represen-
tative collection of porcine E. coli strains based on in vitro
growth experiments, 2) estimation of concentration-time
profiles of ampicillin following IM treatment, based on lit-
erature data, and 3) predictions of the competitive growth
of multiple E. coli strains with varying duration and fre-
quency of IM ampicillin treatment and with varying excre-
tion rates of bacteria from the intestine, corresponding to
the effect of diarrhea.
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In vitro growth response of E. coli strains to ampicillin
Fifty E. coli strains were randomly selected from the Na-
tional Antimicrobial Resistance monitoring program to
represent the population of commensal E. coli from pigs
in Denmark [23]. These strains were used as a founda-
tion to study the effect of ampicillin on the growth dy-
namics of sensitive and resistant strains. Among the
randomly chosen strains, 13 (26 %) were found to be re-
sistant to ampicillin with an MIC ≥ 32 μg/ml (Fig. 1a).
The strains were exposed to ampicillin in triplicate at a
range of constant concentrations from 0.06 to 256 μg/ml
(see Methods). Single net bacterial growth rate at corre-
sponding concentration was estimated from the growth
curves, using an exponential model fit to triplicates as
repeated measures. These estimated rates were assessed
using fit curve and confidence intervals (data not shown).
A relationship between ampicillin concentrations and net
bacterial growth rates was obtained for each strain, and an
Emax model was fitted to this relationship based on three
PD parameters.
No relation was found between the MIC of the strain
and net growth rates in the absence of a drug (maximum
growth rate, αmax), and the mean growth rate of
susceptible and resistant strains did not differ signifi-
cantly, indicating that the resistant strains did not carry
a fitness cost for their resistance (Fig. 1b). The hill coef-
ficients (γ), i.e. the steepness of the response curve for
each strain with growing concentration of antibiotic,
were also found not to differ significantly between the
two groups of susceptible and resistant strains, however,
the most susceptible strains with MIC <2 ug/ml appar-
ently were more affected by increasing concentrations of
antibiotics that the rest of the strains (Fig. 1c). A strong
linear relationship was found between MIC and EC50 on
a log-log scale, showing a relation between the point es-
timate and the dynamic activity of the drug (Fig. 1d).
These parameters capture the dynamic relationship be-
tween antimicrobial concentration and net growth rate
and should be considered along with MIC when evaluat-
ing treatment strategies. These parameters were used in
the mathematical model to predict in vivo growth.
Pharmacodynamics of ampicillin in pigs following IM
ampicillin treatment
The plasma concentration profile in pigs after an IM
ampicillin treatment was obtained from literature and
Fig. 1 a Distribution of strains according to MIC values. b, c, d The three PD parameters for the 50 E. coli strains versus their MIC values shown as
means with 95 % confidence intervals. The green line represents susceptible strains and the red line represents resistant strains
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was fitted to a two-compartment model [24]. Different
concentration profiles were simulated using estimated
transfer rates based on the combinations of dosing fac-
tors. In all of the simulated profiles, concentrations
remained below the cut-off value between resistant and
susceptible strains (16 μg/ml) in the intestine, due to fast
elimination from the body, indicating a poor likelihood
that IM ampicillin treatment can be used to eliminate
the more resistant part of the commensal E. coli flora,
even if concentrations were increased above the recom-
mended dose (data not shown).
Modeling the effect of IM treatment with ampicillin on
dynamics of commensal E. coli in the intestine of pigs
To model the effect of treatment on the growth of
sensitive and resistant strains, 12 strains (four of
which were resistant to ampicillin) and their charac-
teristics were randomly selected among the 50 strains
as inhabitant of the intestine in pigs treated IM with
ampicillin. Growth dynamics of strains before, during
and after treatment was measured in four different
ways (Additional file 1: Figure S1: Growth of individ-
ual strains (Additional file 1: Figure S1, top-left), the
sum of susceptible and resistant counts (Additional
file 1: Figure S1, top-right), a 95 % simulation enve-
lope around the mean value from 100 repeats, (Additional
file 1: Figure S1, bottom-left), and in fractions of mean
values of resistant and susceptible bacteria (Additional
file 1: Figure S1, bottom-right).
Among the treatment-combinations tested, the model-
ing revealed that short treatment duration resulted in
the lowest fraction of resistant strains after treatment
and, consequently, a faster return to equilibrium (Fig. 2).
The effect of dosing frequency (with fixed amount of
antibiotic) on the fraction of resistance was found to be
low, however, the differences increased with longer
treatment durations (Fig. 2). A summary of the predicted
resistance fractions at three time points for the tested
treatment strategies can be seen from the (Additional
file 1: Figure S2). The effect of increased daily dose was
also modelled, resulting in higher resistance levels with
higher daily doses (Fig. 3).
Besides dosing factors, other parameters may have
an effect on the growth of resistant bacteria and
could play an important role when deciding upon op-
timal treatment strategies, and uniquely our modeling
incorporated such factors in the modeling scenarios.
The number of different commensal E. coli harbored
by each pig may vary considerably [25], and to
investigate the importance of this for resistance devel-
opment, we modeled growth dynamics in the pig in-
testine with different numbers of competing strains.
The number of strains was found only to influence
on resistance levels following long treatment duration,
while it was not important for shorter treatment
times (Fig. 4). In addition, for longer treatment dura-
tions, the simulations revealed a tendency that pigs
with fewer strains more quickly returned to the pre-
treatment equilibrium in the intestine (Fig. 4).
Pigs with diarrhea can be assumed to excrete bacteria,
including E. coli in larger quantities than pigs without
diarrhea. To investigate the importance of this
phenomenon, the model incorporated the excretion of a
proportion of the bacterial population. When this was
included, higher resistance levels were found for higher
outflow rates during treatment (Fig. 5), yet resistance
dropped faster post-treatment (Fig. 5, top). However, if
the increased outflow rate was limited to the treatment
period (corresponding to a situation where the treatment
results in a cure), the opposite was observed: resistance
levels dropped more slowly after the treatment end
(Fig. 5, bottom).
Fig. 2 Total resistance fraction over time for a composition of 12 strains at varying treatment frequencies (colours) and durations (sub-plots). The
treatment window is shown by the vertical dotted lines
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Fig. 3 Total resistance fraction over time for competitive growth of 12 strains at different daily doses (colours) of ampicillin IM treatment. A 5-day
long treatment duration is shown as vertical dotted lines with one treatment per day
Fig. 4 Fraction of total resistant counts over time for nine combinations of dosing factors where different colors represent the number of
competing strains K. Vertical lines depict the treatment windows. Each row of the panel represents different treatment durations (3, 5, 8 days) and
each column of the panel represents changing dosing frequencies (once every 2 days, once a day, twice a day)
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Discussion
The current study modeled the effect of IM ampicillin-
treatment strategies in pigs on the balance between
sensitive and resistant E. coli strains in the intestine of
the pig, in order to be able to recommend improved
treatment strategies that can be further elaborated. To
compare treatment strategies by field-testing is very
cumbersome, and our approach therefor constitutes a
shortcut to better treatment strategies. It must be
stressed that further investigations with the treatment
strategies that revealed the least resistance development
should be carried out.
Our model simulated the competition between mul-
tiple bacterial strains (including both susceptible and
resistant ones) representative of the Danish natural
population of pig E. coli. In contrast to previous studies
[17, 19–22], we used dynamic plasma concentration pro-
files of a drug, as opposed to the use of static PK param-
eters, we based our modeling on growth parameters on
a representative collection of naturally occurring por-
cine, commensal E. coli strains, we modeled resistance
development taking into account that different pigs may
harbor different numbers of commensal E. coli, and we
included the fact that some pigs may shed bacteria in
higher numbers due to diarrhea in our modeling. Since
the approach taken in genuine, it sets a model for future
modeling studies with other antibiotics and other live-
stock species.
Growth curves were obtained using the BioScreen for-
mat, which allowed us to expose many strains to a range
of static concentrations of ampicillin to create input data
for our modeling, rather than the small number possible
in manual growth experiments. We did not observe a fit-
ness cost of carrying ampicillin resistance in the current
study. Although some of the resistant strains were found
to have a reduced growth rate compared to susceptible
strains, there was no overall difference in growth be-
tween the susceptible and resistant groups, which sug-
gests that the fitness cost associated with the resistance
mechanisms in our strains was small. We have not char-
acterized the mechanism responsible for ampicillin re-
sistance in our study, and further studies are needed to
Fig. 5 Mean resistant fraction of bacterial counts for 100 model repeats with varying outflow rate. Outflow rates were first kept constant
throughout the simulated time (top), and secondly set to 0.01 outside treatment time (bottom)
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elucidate whether the observation of low fitness cost is
associated with one or more resistance mechanisms.
Commensal E. coli strains from pigs in Denmark are
commonly resistant to tetracycline, and we have previ-
ously shown a lack of fitness cost associated with resist-
ance to this drug [23, 25]. In contrast to the growth
rates, a linear relation between EC50 and MICs on the
log-log scale was observed. This indicates that the differ-
ence between strains in their ability to degrade ampicil-
lin is not dependent on the ampicillin concentration—an
observation that deserves further attention.
Due to the high number of strains characterized, the
parameters used as input to our model study are more
epidemiologically realistic than those from previous
studies, which based growth modeling on a limited num-
ber of strains, mostly of clinical origin [26–29]. Coexist-
ence of multiple strains in our model was achieved by
using a double growth restriction term as also used in
our recently published studies [24, 30]. The double
growth restriction term enables a dynamically balanced
system where no strain conquers the system. Previous
studies used single growth restriction terms. This can
lead to a situation where one strain with a high growth
rate outgrows all other strains, and it is not possible for
equilibrium to be established. A biological interpretation
of the double growth restriction is that the total popula-
tion cannot exceed the carrying capacity due to the lim-
ited availability of nutrients and space, and the full
resource cannot be used by a single strain, since it will
alter the growth conditions when it removes the nutri-
ents on which its superior growth abilities are based.
Conjugation or other modes of transfer of resistance
were not included in the model, as the impact of such
events was assumed to be generally unimportant given
the previously established resistant population in mod-
ern pig production [31].
The modeling found that short treatment duration re-
sulted in less selection of resistant bacteria than longer
durations. This finding is in agreement with a previous
modeling study [22]. The most logical explanation is that
this is the case because this strategy gives resistant
strains less time to outcompete susceptible strains under
sub-MIC concentrations. Only a very small variation in
resistance was observed for different dosing frequencies
(the same amount of drug dispersed over different
lengths of time). We also observed that the number of
competing strains only had a very small effect on the
final proportion of resistant strains, when using short
treatment duration. In contrast, for longer treatment
durations, higher resistance levels were observed with
increased number of resistant strains. Together, these
results indicate that provided the treatment is clinically
effective, it will always be an advantage to keep the dur-
ation of treatment as short as possible. Based on these
results, it would be valuable to test different strategies
for ampicillin with short-duration treatment in field-
testing in pigs, in order to support recommendations for
new treatment protocols.
No in vivo studies on the importance of increased bac-
terial excretion, for example as a consequence of diar-
rhea, on resistance development has been carried out.
One modeling based study has indicated that the spread
of resistant bacteria between pigs plays an important
role in the balance between resistant and sensitive
strains following treatment, favoring resistant strains
[30]. In the current study, the outflow rate was also
found to influence the proportion of resistant strains.
When diarrhea was assumed to disappear at the end of
treatment, the higher outflow rate during treatment re-
sulted in higher numbers of resistant bacteria, while
continuous diarrhea was associated with a rapid return
of resistant bacteria after treatment. Thus, bacterial ex-
cretion appears to drive the speed at which the system
equilibrates. Whether this occurs in reality remains to
be investigated, but among other factors, it will depend
on whether the different strains have the same ability to
adhere to the intestine. As mentioned, a previous model-
ing study suggested that increased outflow will tend to
favor resistant strains for groups of more than one pig
following oral treatment with tetracycline [30], and this
factor has to be considered together with our observa-
tions to have the full picture.
Conclusions
Our model predictions showed that short treatment
duration with ampicillin (IM) will result in fewer re-
sistant E. coli in the intestine of the treated animal
and a faster return to equilibrium. The effect of dosing
frequency was higher for longer treatment durations. Be-
sides dosing factors, the epidemiological factors (such as
number of competing strains and bacterial excretion) need
to be considered further before designing optimal treat-
ment strategies. The modeling approach used in the study
is generic, and could be used for evaluation of the effect of
treatment with other drugs and other administration
routes for predicting resistance levels in pigs.
Methods
Pharmacodynamics
As part of the DANMAP 2010 report, 160 E. coli strains
were collected from fecal samples of healthy pigs at
slaughter [32]. From these, a total of 50 E. coli strains
were randomly selected for in vitro experiments. The 50
E. coli isolates had previously been subcultured and con-
firmed as E. coli by biochemical tests (lactose and indole
test) and MALDI-TOF MS analysis [23]. The susceptibil-
ity towards ampicillin was tested by broth microdilution
according to the CLSI standards [33]. Two-fold dilutions
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of ampicillin sodium salt (Sigma-Aldrich, Switzerland)
from 0.125 to 1024 μg/ml were prepared in Cation-
Adjusted Müllel-Hinton Broth (CAMHB) and distrib-
uted in microtitre plates. CAMHB without ampicillin
were included to serve as positive growth controls. The
plates were inoculated with dilutions of 0.5 McFarland
turbidity standard adjusted bacterial saline suspensions,
prepared from overnight cultures on blood agar. Final
bacterial concentration in each well was approxi-
mately 5 × 105 CFU/ml. The E. coli reference strain
E. coli ATCC25922 was used as quality control. Strains
with MIC ≤ 8 μg/mL were considered to be ampicillin sus-
ceptible, and strains with MIC ≥ 32 μg/mL were consid-
ered ampicillin resistant [34].
Growth curves for the effect of ampicillin on the 50 E.
coli strains were performed using the automated micro-
biology growth curve analysis system BioScreen C™ (Oy
Growth Curves Ab Ltd, Finland). All isolates were grown
without antibiotics, as well as with two-fold dilutions of
ampicillin sodium salt; ampicillin susceptible isolates
were grown in two-fold dilutions from 0.06 to 16 μg/mL
ampicillin, and resistant isolates in two-fold dilutions
from 1 to 256 μg/mL ampicillin. Ampicillin suspensions
and bacterial inoculum were prepared as described above.
The final volume in each well was 200 μl, with a final in-
oculum concentration of approximately 5 × 104 CFU/ml.
Blank samples of all ampicillin dilutions as negative
growth controls, as well as the E. coli ATCC25922 strain
for plate-to-plate comparisons, were included on all plates.
The plates were placed in the BioScreen and incubated at
37 °C with continuous shaking, and optical density (OD)
at a wavelength of 600 nm was measured every 5 min for
18 h. All BioScreen growth experiments were performed
in biological triplicates. For the strains with an MIC
greater than the treated ampicillin concentrations, no
growth was considered at a concentration equal to or
above the MIC.
Raw data from the BioScreen were extracted in Micro-
soft Excel. OD values of the blank samples were sub-
tracted from the measured OD values of the samples at
their respective ampicillin concentration and time point.
In this study, the maximum reliable OD value for which
a linear relationship between OD and CFU was consid-
ered valid was set as 0.1. An exponential equation (eq. 1)
was fitted to the growth curve below the OD value of
0.1 to estimate the net bacterial growth rates at corre-
sponding ampicillin concentrations using a nonlinear
least square algorithm nls() function of the R software
(version 3.1.2 for windows) [35].
Y t ¼ μeαt þ βþ εt ð1Þ
Where Yt is the OD value, μ is the initial OD value at
time zero, is the growth rate, β is an offset variable
for the adjustment of μ, and εt a normal error with mean
zero and constant variance σ2; i.e., ϵt =N(0, σ
2).
The relationship between ampicillin concentrations
and the estimated net bacterial growth rates was estab-
lished and analyzed using the three parameter Emax
model (known as the Hill equation) as below:
a cð Þ ¼ amax−
amax cEC50
 γ
1þ cEC50
 γ ð2Þ
where amax is the bacterial growth rate in the absence of
the drug (maximum effect); EC50 is the concentration at
which the drug effect is reduced to 50 %; and γ denotes
the Hill coefficient, which is the measure of the steep-
ness of the sigmoid relationship between concentration c
and the growth rate at concentration c. The PD model
parameters amax and γ were compared for susceptible
and resistant strains using the Wilcoxon rank-sum test
in R and the linear relation between MIC and EC50 was
analyzed using the lm() function in R.
Pharmacokinetics
The mean plasma concentrations of ampicillin after IM
treatment in pigs was taken from the literature [36]. A
two-compartmental PK model was fitted to the values of
the plasma concentration and time profile to estimate the
transfer rates between two compartments. The two com-
partments included a central compartment and a periph-
eral compartment as previously described [24], but fitted
with ampicillin. Based on the estimated rates, different
concentration-time profiles for different combinations of
treatment durations and dosing frequencies delivering the
same daily dose of 40 mg/kg were simulated. These differ-
ent concentration-profiles were incorporated into the
model as described in the next section. Moreover, to in-
vestigate the effect of different daily doses, concentration-
time profiles were incorporated into the model for a range
of daily doses of (10, 20, 30, 40, 50, 60) mg/kg.
The PK-PD Model
We modeled the changes in the bacterial counts of indi-
vidual bacterial strains in a pig using growth parameters
from the PD model, combined with the in vivo drug pro-
file using an ordinary differential equation [24] given by:
dNi
dt
¼ αmax;i 1− c
γ i
cγ i þ ECγi50;i
0
@
1
A Nmax−Ni
Nmax
 
 Nmax−
X
Ni
Nmax
 !
Ni−φNi
ð3Þ
The left hand side of the equation shows the changes
in the bacterial counts Ni of strain i. The first bracketed
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term on the right hand side of the equation gives the
drug efficacy as a function of the three PD model pa-
rameters (amax, EC50, γ), and the in vivo drug
concentration-time profile c. The remaining bracketed
terms are density-dependent limitations to growth,
which depend on the carrying capacity, Nmax, and the
total bacterial counts summed over all competing
strains in the pig, ΣNi. The final term is the excretion
of strains from a pig with an outflow rate φ [30].
Firstly, 12 E. coli strains were randomly drawn from
the 50 strains, along with their PD parameters. The
model was allowed to run without antimicrobial treat-
ment with these 12 strains competing in the pig intestine
in order to establish dynamic equilibrium (Additional
file 1: Figure S3, without treatment). The dynamic equi-
librium was defined as the stage at which multiple
strains co-exist with very small changes over a long
period of time, in the absence of the drug. During the
treatment period, however, antimicrobial pressure tem-
porarily disturbs the equilibrium (Additional file 1:
Figure S3, with treatment). Strains would return to a
state of equilibrium when treatment stopped, but could
differ from the pre-treatment equilibrium. A dynamic
equilibrium could only be established in our model
when the outflow rate was less than the maximum
growth rate of the individual strains (i.e. φ < αmax).
Different treatments were introduced once the equilib-
rium was attained, with the first treatment day denoted
as Day 0 (Additional file 1: Figure S3). The model was
allowed to run for a period of 35 days to assess the effect
of dosing factors on the post-treatment growth dynam-
ics. To capture the variation in growth characteristics
and susceptibility levels in the mix of strains, this was
repeated 100 times with 12 E. coli strains. In each repeat,
12 different strains were randomly drawn from 50 E. coli
strains. To assess the influence of the number of com-
peting strains, model predictions were also made with
the inclusion of only six and then three competing
strains.
A homogenous distribution of the bacterial population
was assumed within the intestine of a pig [37]. A plasma
concentration profile was used to represent the bacteria-
drug interaction after an IM injection, as plasma concen-
tration is often used as a surrogate for the concentration
at the site of interaction, which in this case is the intestine
[38]. To capture the effect of excretion, the outflow rate
was varied both during the treatment as well as through-
out the simulation period.
The carrying capacity Nmax was set to 10
10 bacteria.
An outflow rate, φ, of 0.01 per hour was taken from a
published experimental study that estimated the hourly
fractional inflow and outflow of E. coli “free-living” in
the large intestine from an in vivo study in post-weaned
dairy calves [20, 39]. The initial numbers of individual
strains were randomly selected in the interval 106 to 109
with the total sum not exceeding the carrying capacity
of 1010. A seed was set before the model run to allow
runs with the same strains and initial values under dif-
ferent treatment protocols to be compared. As around
30 % of detected E. coli were ampicillin-resistant in the
Danish surveillance scheme, competing strains were
selected with a proportion of one third (i.e., 4, 2 or 1)
resistant [8_ENREF_30]. The model was written in R
(version 3.1.2 for windows) [35], and all data were ana-
lyzed and graphed using R.
Additional file
Additional file 1: Figure S1. Bacterial counts over time for 12
individual competing strains in a pig intestine, represented by
different colours (top-left). Sum of susceptible (black) and resistant
(red) counts (top right). Mean with 95 % simulation envelope from
100 model repeats (bottom left). Mean fraction of resistant counts
over time (bottom right). Figure S2. Mean resistance fraction with
95 % simulation error bars from 100 model repeats at three different
time points: day 0, day max and day 35. Day max represents the day
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Bacterial counts over time for 12 competing strains (different colours) with
different growth characteristics without treatment (left), and with treatment
(right). Vertical dotted lines indicate treatment duration. (PDF 466 kb)
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